Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease

ClinicalTrials.gov ID: NCT00106314

Public ClinicalTrials.gov record NCT00106314. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 12:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multi-Center, Dose Response, Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Moderately Active Crohn's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of Inflabloc Cap (Dehydroepiandrosterone \[DHEA\]) in the treatment of patients with moderately active Crohn's disease.

Study identification

NCT ID
NCT00106314
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Inflabloc Pharmaceuticals
Industry
Enrollment
75 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2005 (Type not available)
Primary completion
Not listed
Completion
Oct 2006 (Actual)
Last update posted
Oct 19, 2007

2005 – 2006

United States locations

U.S. sites
29
U.S. states
22
U.S. cities
28
Facility City State ZIP Site status
Clinical Research Associates Huntsville Alabama 35801 —
Advanced Clinical Research Institute Anaheim California 92801 —
Sharp Rees-Stealy Medical Group San Diego California 92123 —
Clinical Research of West Florida Clearwater Florida 33765 —
Borland-Groover Clinic Jacksonville Florida 32256 —
Atlanta Gastroenterology Associates Atlanta Georgia 30342 —
Northwest Gastroenterologists Arlington Heights Illinois 60005 —
The University of Chicago Hospital Chicago Illinois 60637 —
University of Louisville, Department of Internal Medicine Louisville Kentucky 40202 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Maryland Clinical Trials Severna Park Maryland 21146 —
Jason Bodzin, MD Farmington Hills Michigan 43884 —
AGA Clinical Research Associates Egg Harbor New Jersey 08234 —
New York Center for Clinical Research Lake Success New York 11042 —
Charlotte Gastroenterology and Hepatology Charlotte North Carolina 28207 —
Consultants for Clinical Research Cincinnati Ohio 45219 —
The Cleveland Clinic Foundation, Dept. of Gastroenterology Cleveland Ohio 44195 —
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Allegheny Center for Digestive Health Pittsburgh Pennsylvania 15212 —
The Medical University of South Carolina Charleston South Carolina 29425 —
Nashville Medical Research Institute Nashville Tennessee 37205 —
Atilla Ertan, MD Houston Texas 77030 —
Mountain West Gastroenterology Salt Lake City Utah 84121 —
SMG Reseach Salt Lake City Utah 84124 —
University of Vermont College of Medicine / Fletcher Allen Health Care Burlington Vermont 05403 —
McGuire DVAMC GI (111N) Richmond Virginia 23249 —
University of Washington Medical Center, Department of Gastroenterology Seattle Washington 98195 —
Tacoma Digestive Disease Research Center Tacoma Washington 98405 —
Wisconsin Center for Advanced Research Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00106314, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2007 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00106314 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →